A drug product combines pharmacologic activity with pharmaceutical properties. Desirable
performance characteristics are physical and chemical stability, ease of processing …

In cystic fibrosis inhalation of drugs for the treatment of CF related lung disease has been
proven to be highly effective. Consequently, an increasing number of drugs and devices …

Drugs for inhalation are no longer exclusively highly crystalline small molecules. They may
also be amorphous small molecules, peptides, antibodies, and myriad types of engineered …

The use of dry powder inhalers (DPIs) to administer treatments for respiratory diseases has
increased significantly in recent years. There is now a wide range of DPIs available that vary …

Multiple types of aerosol devices are commonly used for the administration of medical
aerosol therapy to patients with pulmonary diseases. All of these devices have been shown …

BACKGROUND: Dry powder inhalation (DPI) may be an alternative to nebulisation of drugs
in the treatment of chest infections in cystic fibrosis (CF) patients. In a pilot study the …

In the context of streamlining generic approval, this study assessed whether
pharmacokinetics (PK) could elucidate the pulmonary fate of orally inhaled drug products …

The pressurized metered dose inhalers and dry powder inhalers are the most widely used
devices for inhalation therapy in asthma and chronic obstructive pulmonary disease; each of …

THE ISSUES surrounding the use of inhaled ther-apy in children are essentially the same as
those in adults. Patients must be given a device that they can and will use effectively—the …

The drug product encompasses the pharmacologic activity with the pharmaceutical
properties. The ideal characteristics are physical and chemical stability, ease of processing …